Company · CIK 0001750284 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Olema Pharmaceuticals, Inc. · OLMA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 23, 2026 SForm 4 → | Jul 27, 7:30 pm EDT | Cyrus HarmonDirector | 25,000 | $11.65 | $291,163 | 702,770 | −3.44% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 AForm 4 → | Sep 2, 4:30 pm EDT | Jason O'ByrneCHIEF FINANCIAL OFFICER | 650,000 | — | — | 650,000 | — |